December 2,
2013 |
Singulex to Present at 25th Annual Piper Jaffray Healthcare Conference
|
November 19,
2013 |
Singulex’s Assay for Cardiovascular Risk Assessment Highlighted in Two Presentations at AHA 2013 Scientific Sessions
|
October 29,
2013 |
Singulex Announces Key Additions to Executive Management Team
|
September 26,
2013 |
Singulex Secures $55 Million in Debt and Equity Financing
|
July 31,
2013 |
Singulex’s Erenna® Single Molecule Counting (SMC™) Technology an Enabling Factor in Two Award Winning Studies Presented at the AACC Annual Meeting
|
May 23,
2013 |
Singulex Names Guido Baechler President and Chief Executive Officer
|
March 8,
2013 |
New Data from TIMI Study Group to Be Presented at American College of Cardiology Scientific Session Show Prognostic Value of High-Precision Cardiac Troponin Monitoring
|
May 1,
2012 |
Singulex Adds IL-17A/F to Suite of TH17 Pathway Immunoassay Kits
|
March 22,
2012 |
High Sensitivity Cardiac Troponin-I Assay Could Identify Future Risk for Dying from Cardiovascular Disease
|
December 14,
2010 |
Singulex Announces Issuance of U.S. Patents for Single Molecule Detection of Protein Biomarkers and Key Biomarker for Cardiac Risk Monitoring
|